Pharmafile Logo
Pharmafocus logo
Advanced Search

US direct-to-consumer advertising attacked

August 16, 2007
Sales and Marketing

Direct-to-consumer advertising by the US pharmaceutical industry has come under attack again, with the latest research showing that promotion of …

News

Conflict over plans to improve out-of-hours services

August 15, 2007

Doctors have attacked government plans to allow more non-medically qualified staff to run out-of-hours services.The row follows a recent report …

News

Is London’s revamp a taste of things to come for the NHS?

August 15, 2007

A review of the NHS in London has recommended setting up a network of 150 polyclinics to take on much …

News

Is it R.I.P. for the PPRS?

August 15, 2007
Sales and Marketing ABPI, par

News

News from Datamonitor

August 13, 2007
Research and Development, Sales and Marketing

Alnylam lands $38.6 million federal government contractAlnylam Pharmaceuticals has been awarded a $38.6 million contract over 33 months from the …

News

The NHS and pharma: Let’s work together

August 13, 2007
Research and Development, Sales and Marketing NHS, healthcare, industry relations, joint working, pharma

In the last 10 years, pharma’s relationship with the NHS has undergone a transformation. For one thing, it’s difficult now …

Feature

NICE claims victory in Alzheimer’s court case

August 10, 2007
Sales and Marketing Alzheimer's

NICE will have to issue new guidance on Alzheimer's drugs, but claims the ruling in the judicial review vindicates its …

News

NICE to re-think blindness drugs decision

August 9, 2007
Sales and Marketing AMD, Lucentis, Macugen, NICE

NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …

News

FDA approves Pfizer’s first-in-class HIV drug

August 8, 2007
Sales and Marketing HIV

Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …

News

Indian court dismisses Novartis patent claim

August 8, 2007
Sales and Marketing India, Novartis

Novartis has failed in its challenge to India's intellectual property laws as part of its attempt to secure a patent …

News

Bayer buoyed by Schering integration

August 8, 2007
Sales and Marketing

Bayer more than doubled its second quarter pharma sales, which rose to €2.6 billion on the back of the group's …

News

First national dementia strategy planned

August 7, 2007

Plans have been unveiled for the first-ever national dementia strategy as the scale of the problem becomes clear.The number of …

News

Close encounters with the NHS

August 6, 2007
Research and Development, Sales and Marketing NHS, healthcare, industry relations, pharma

Most marketers in the pharma industry understand the need to get alongside and talk to key people in the NHS …

Feature

News roundup from Datamonitor

August 3, 2007
Sales and Marketing

Astion's lupus drug to receive orphan statusEuropean health authorities have recommended that Copenhagen-based Astion Pharma's cutaneous lupus erythematosus candidate be …

News

FDA allows Avandia to stay but damage already done

August 3, 2007
Sales and Marketing diabetes

An FDA advisory committee has recommended that GlaxoSmithKline's diabetes treatment Avandia should remain available on the US market, albeit with …

News

Germany loses out in Astellas restructuring

August 2, 2007
Sales and Marketing Astellas, Germany

Astellas has announced streamlining and cutbacks to its operations across Europe, with operations in Germany losing staff in its saleforce …

News

Tough talking ahead as government signals end to UK medicines pricing deal

August 2, 2007
ABPI, par

The government has told the UK pharmaceutical industry it wants to talk about the future of medicines pricing in the …

News

ReNeuron acquires Californian base and new diabetes technology

August 2, 2007
Research and Development

Pioneering British stem cell research company ReNeuron has bought the Californian company, AmCyte – a move it hopes will make …

News

Prevenar success boosts UK manufacturing

July 30, 2007
Manufacturing and Production

Wyeth has increased the capacity at its manufacturing site in Havant, Hampshire in response to growing demand for its vaccine …

News

Continuous dose contraceptive launched in US

July 30, 2007
Sales and Marketing contraception

Wyeth's Lybrel, the first ever contraceptive pill designed to be taken by women 365 days a year, has been launched …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025